Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: MF17, LFA-1, LCAMB, LAD, ITGB2
Anti-CD18 Monoclonal Antibody
(9O393)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 20 µL | Inquiry | 7-10 days | 7-10 days | |
| 50 µL | Inquiry | 7-10 days | 7-10 days | |
| 100 µL | Inquiry | 7-10 days | 7-10 days |
| Description | Anti-CD18 Monoclonal Antibody (9O393) is a Mouse antibody targeting CD18. Anti-CD18 Monoclonal Antibody (9O393) can be used in IF. |
| Synonyms | MF17, LFA-1, LCAMB, LAD, ITGB2 |
| Ig Type | IgG2b |
| Clone | 9O393 |
| Reactivity | Human,Mouse |
| Application | |
| Recommended Dose | IF: 1/200-1/1000 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Purified by protein A or protein G |
| Appearance | Liquid |
| Formulation | PBS with 0.05% sodium azide |
| Concentration | 1 mg/ml |
| Research Background | CD18, also known as ITGB2 (integrin beta chain beta 2). Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. For example, beta 2 combines with the alpha L chain to form the integrin LFA-1, and combines with the alpha M chain to form the integrin Mac-1. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. CD18 is expressed by most leucocytes. Defects in this gene are the cause of leukocyte adhesion deficiency type I (LAD1). Two transcript variants encoding the same protein have been identified for this gene. |
| Conjucates | Unconjugated |
| Immunogen | Purified recombinant fragment of CD18 expressed in E. Coli. |
| Antigen Species | Human |
| Gene Name | ITGB2 |
| Gene ID | |
| Protein Name | Integrin beta-2 |
| Uniprot ID |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.